GB1115703A - Pharmaceutical anti-androgenic composition and dosage units thereof - Google Patents
Pharmaceutical anti-androgenic composition and dosage units thereofInfo
- Publication number
- GB1115703A GB1115703A GB8518/66A GB851866A GB1115703A GB 1115703 A GB1115703 A GB 1115703A GB 8518/66 A GB8518/66 A GB 8518/66A GB 851866 A GB851866 A GB 851866A GB 1115703 A GB1115703 A GB 1115703A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dosage units
- pharmaceutical anti
- androgenic composition
- androgenic
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000002280 anti-androgenic effect Effects 0.000 title abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 abstract 1
- 229960004675 fusidic acid Drugs 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8518/66A GB1115703A (en) | 1966-02-25 | 1966-02-25 | Pharmaceutical anti-androgenic composition and dosage units thereof |
| FR96360A FR6104M (enrdf_load_stackoverflow) | 1966-02-25 | 1967-02-24 | |
| BE694586D BE694586A (enrdf_load_stackoverflow) | 1966-02-25 | 1967-02-24 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8518/66A GB1115703A (en) | 1966-02-25 | 1966-02-25 | Pharmaceutical anti-androgenic composition and dosage units thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1115703A true GB1115703A (en) | 1968-05-29 |
Family
ID=9853978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8518/66A Expired GB1115703A (en) | 1966-02-25 | 1966-02-25 | Pharmaceutical anti-androgenic composition and dosage units thereof |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE694586A (enrdf_load_stackoverflow) |
| FR (1) | FR6104M (enrdf_load_stackoverflow) |
| GB (1) | GB1115703A (enrdf_load_stackoverflow) |
-
1966
- 1966-02-25 GB GB8518/66A patent/GB1115703A/en not_active Expired
-
1967
- 1967-02-24 FR FR96360A patent/FR6104M/fr not_active Expired
- 1967-02-24 BE BE694586D patent/BE694586A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR6104M (enrdf_load_stackoverflow) | 1968-06-10 |
| BE694586A (enrdf_load_stackoverflow) | 1967-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1330878A (en) | Ketamine resolution | |
| GB1263000A (en) | 4,4',4''-trihydroxytriphenylmethylmethane and process for preparing it | |
| IL34713A (en) | Anaesthetic pharmaceutical preparations containing 3alpha-hydroxy-5alpha-pregnane 11,20-dione | |
| AU8251275A (en) | Pharmaceutical compositions comprising 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid, and their uses | |
| IL37280A0 (en) | New adenosine-5'-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| GB1115703A (en) | Pharmaceutical anti-androgenic composition and dosage units thereof | |
| GB1281719A (en) | Anti-haemorrhoidally active preparations for local or rectal administration | |
| GB1049996A (en) | New medicine with anti-inflammatory and anti-rheumatic activity | |
| GB1125924A (en) | Organic bismuth derivative | |
| GB1117305A (en) | Testosterone derivatives | |
| GB1066885A (en) | Therapeutic agent and compositions having the inhibitory action for ª‰-glucuronidase and method of inhibiting ª‰-glucuronidase | |
| GB1200928A (en) | Medicine for the treatment of hemeralopia | |
| CA957280A (en) | Progestational composition in oral dosage form | |
| ES376409A1 (es) | Procedimiento para la preparacion de 21-enantato de 9-alfa - fluor-16-fluormetilen-prednisolona. | |
| GB1196454A (en) | Improvements in Dermatological Compositions | |
| GB1410830A (en) | Acne treatment | |
| KATADA et al. | A consideration on the effect of concrete beds set up for the cultivation of Iwanori Studies on the efficiency of the utility of sea-weeds cultivation. III | |
| GB1230687A (enrdf_load_stackoverflow) | ||
| AU414340B2 (en) | Medicinal compositions for administration to animals and process for administering same | |
| GB1036282A (en) | Pregnane-aldehyde and derivatives thereof | |
| CA979363A (en) | Anti-inflammatory agents and process for their preparation | |
| AU3469468A (en) | Medicinal compositions for administration to animals and process for administering same | |
| GB1207745A (en) | A tranquillizer-containing composition | |
| AU4947564A (en) | Pharmaceutical compositions containing 2,4,6 trihydroxy benzonic acid and its salts | |
| GB1194912A (en) | Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin |